(Q68161660)
Statements
A controlled dose-ranging study of remoxipride and haloperidol in schizophrenia--a Canadian multicentre trial (English)
Lapierre YD
Nair NP
Chouinard G
Awad AG
Saxena B
Jones B
McClure DJ
Bakish D
Max P
1 January 1990